8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T60919 | SARS-CoV-2-IN-13 | SARS-CoV | |
SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when ad... | |||
T74807 | SARS-CoV-2 3CLpro-IN-13 | ||
SARS-CoV-2 3CLpro-IN-13 is a potent inhibitor of the SARS-CoV-2 3CL protease, demonstrating significant anti-coronavirus activity with an IC50 value of 21 nM [1]. | |||
T62264 | SARS-CoV-2 nsp13-IN-2 | ||
SARS-CoV-2 nsp13-IN-2 (Compound C2) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 42 μM). | |||
T62375 | SARS-CoV-2 nsp13-IN-3 | ||
SARS-CoV-2 nsp13-IN-3 (Compound C3) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 32 μM). | |||
T62413 | SARS-CoV-2 nsp13-IN-1 | ||
SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent inhibitor of nsp13 (non-structural protein 13). SARS-CoV-2 nsp13-IN-1 inhibits only nsp13 ssDNA+ATPase (IC50: 6 μM), but not ssDNA-ATPase. CoV-2 nsp13-IN-1 was able to be u... | |||
T62248 | SARS-CoV-2 nsp13-IN-6 | ||
SARS-CoV-2 nsp13-IN-6 (compound C5) is a potent inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on ssDNA+ATPase (IC50: 27 μM) and ssDNA-ATPase (IC50: 33 μM). nsp13-IN-6 can be used in anti-COVID-19 st... | |||
T78719 | SARS-CoV-2-IN-47 | SARS-CoV | |
SARS-CoV-2-IN-47 (Compound 13), with IC50 values of 0.77 μM against Omicron BA.1 and 0.93 μM against the Delta strain, serves as an inhibitor of SARS-CoV-2 and is applicable in antiviral research [1]. | |||
T40358 | Ensitrelvir fumarate | S-217622 fumarate | |
Ensitrelvir (S-217622) fumarate is a novel orally active inhibitor, targeting the SARS-CoV-2 3CL protease (IC50 = 13 nM). It demonstrates non-covalent and non-peptidic characteristics. This compound represents a pioneeri... |